Scotiabank Maintains Sector Outperform on Merck & Co, Raises Price Target to $180

Scotiabank analyst Louise Chen has maintained a Sector Outperform rating on Merck & Co (NYSE: MRK) and raised the price target from $155 to $180. This adjustment reflects a positive outlook on the company's performance in the sector.